Provided by Tiger Trade Technology Pte. Ltd.

Dianthus Therapeutics Inc.

111.10
+1.591.45%
Volume:730.87K
Turnover:81.25M
Market Cap:6.21B
PE:-27.01
High:112.72
Open:110.30
Low:108.95
Close:109.51
52wk High:117.88
52wk Low:22.81
Shares:55.93M
Float Shares:55.87M
Volume Ratio:1.05
T/O Rate:1.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1130
EPS(LYR):-4.2037
ROE:-26.07%
ROA:-17.69%
PB:5.30
PE(LYR):-26.43

Loading ...

Dianthus Therapeutics Director Simon Read Disposes of Common Shares Worth $326,148.9

Reuters
·
Aug 20

U.S. Research Roundup- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies

Reuters
·
Aug 17

Dianthus Therapeutics (DNTH) Receives a Rating Update from a Top Analyst

TIPRANKS
·
Aug 13

Dianthus Therapeutics SVP General Counsel Adam Veness Melepas Saham Senilai USD 2,21 Juta

Reuters
·
Aug 12

Analysts’ Top Healthcare Picks: Dianthus Therapeutics (DNTH), Elanco Animal Health (ELAN)

TIPRANKS
·
Aug 11

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS) and Dianthus Therapeutics (DNTH)

TIPRANKS
·
Aug 10

Dianthus Therapeutics CEO Marino Garcia Reports Disposal of 166,000 Common Shares Worth $17.97 Million

Reuters
·
Aug 08

Viridian Therapeutics Q2 Net Loss Widens as Lumvoa Launch Lifts Costs

Reuters
·
Aug 06

Climb Bio Q2 Net Loss Widens on Pipeline Advancement

Reuters
·
Aug 06

Dianthus Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $158 from $130

THOMSON REUTERS
·
Aug 06

U.S. Research Roundup-Caterpillar, Eli Lilly, McKesson

Reuters
·
Aug 06

Dianthus Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Arcus Biosciences Q2 Revenue Falls Sharply on Lower License Income

Reuters
·
Aug 06

Enliven Therapeutics Q2 Net Loss Widens on Higher Expenses

Reuters
·
Aug 06

Black Diamond Therapeutics Q2 Net Loss Narrows Year over Year

Reuters
·
Aug 06

EyePoint Pharmaceuticals Q2 Revenue Drops on Lower License Income

Reuters
·
Aug 05

Seres Therapeutics Q2 Net Income Turns Positive on VOWST Sale Gain

Reuters
·
Aug 05

Analysts Conflicted on These Healthcare Names: Dianthus Therapeutics (DNTH) and American Well (AMWL)

TIPRANKS
·
Aug 05

Analysts Offer Insights on Healthcare Companies: Dianthus Therapeutics (DNTH) and Viridian Therapeutics (VRDN)

TIPRANKS
·
Aug 05

Dianthus Therapeutics Q2 Net Loss Widens as R&D Costs Rise

Reuters
·
Aug 05